By: Our Staff Reporter
Addis Ababa (Ethiopia Today) June 8, 2026: In a major move to combat the growing global threat of antimicrobial resistance (AMR), the Ethiopian Food and Drug Authority (EFDA) has introduced a stringent new regulatory framework aimed at controlling the use of antibiotics and antimicrobial medicines.
The newly enacted “Rational Medicines Use Control Directive No. 1138/2026” establishes aggressive institutional mandates and harsh legal penalties for non-compliance.
According to Hailemariam Eshete, Head of the Medicine Information and Rational Use Desk at the EFDA, the new directive introduces a massive regulatory oversight framework across the country’s healthcare system.
Under the strict rules, every hospital, health center, and medical facility in Ethiopia is now legally required to establish a dedicated Antimicrobial Stewardship Committee. This committee will be directly responsible for closely monitoring and enforcing the proper use of antimicrobial drugs within their respective institutions.
The directive strictly prohibits any healthcare professional from initiating antimicrobial treatment for a patient without sufficient clinical or laboratory diagnostic evidence.
Hailemariam emphasized that the authority will enforce strict legal measures against violators. Health facilities or professionals found in violation of the directive face an immediate suspension of their professional licenses or certificates of competency for up to 1 year.
Repeated offenses will trigger structured written warnings and severe financial fines based on the gravity of the violation.
For cases that directly jeopardize public safety, the EFDA warned it will implement ultimate administrative actions, including the permanent revocation of professional licenses or institutional certificates of competency.